The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

The Combination of Beta Blockers and Renin-Angiotensin System Blockers Improves Survival in Incident Hemodialysis Patients: A Propensity-Matched Study

Although several studies suggest that the prognosis of hypertensive dialysis patients can be improved by using antihypertensive drug therapy, it is unknown whether the prescription of a particular class or combination of antihypertensive drugs is beneficial during hemodialysis. Methods: We performed...

Full description

Bibliographic Details
Main Authors: José Luño, Javier Varas, Rosa Ramos, Ignacio Merello, Pedro Aljama, Alejandro MartinMalo, Julio Pascual, Manuel Praga, Bernard Canaud, Angel Luis Martin De Francisco, Adelheid Gauly, Francisco Maduell, Alejandro Martin-Malo, José Ignacio Merello, Rafael Pérez-Garcia, Stefano Stuard, Adam Zawada
Format: Article
Language:English
Published: Elsevier 2017-07-01
Series:Kidney International Reports
Subjects:
antihypertensive drug
β-blocker
cardiovascular risk
hemodialysis
renin-angiotensin system blocker
Online Access:http://www.sciencedirect.com/science/article/pii/S2468024917300542

Similar Items

Similar Items